These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
750 related articles for article (PubMed ID: 29898974)
1. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Kanner AM; Ashman E; Gloss D; Harden C; Bourgeois B; Bautista JF; Abou-Khalil B; Burakgazi-Dalkilic E; Llanas Park E; Stern J; Hirtz D; Nespeca M; Gidal B; Faught E; French J Neurology; 2018 Jul; 91(2):82-90. PubMed ID: 29898974 [TBL] [Abstract][Full Text] [Related]
2. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Kanner AM; Ashman E; Gloss D; Harden C; Bourgeois B; Bautista JF; Abou-Khalil B; Burakgazi-Dalkilic E; Park EL; Stern J; Hirtz D; Nespeca M; Gidal B; Faught E; French J Epilepsy Curr; 2018; 18(4):269-278. PubMed ID: 30254528 [No Abstract] [Full Text] [Related]
3. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Kanner AM; Ashman E; Gloss D; Harden C; Bourgeois B; Bautista JF; Abou-Khalil B; Burakgazi-Dalkilic E; Llanas Park E; Stern J; Hirtz D; Nespeca M; Gidal B; Faught E; French J Neurology; 2018 Jul; 91(2):74-81. PubMed ID: 29898971 [TBL] [Abstract][Full Text] [Related]
4. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Kanner AM; Ashman E; Gloss D; Harden C; Bourgeois B; Bautista JF; Abou-Khalil B; Burakgazi-Dalkilic E; Park EL; Stern J; Hirtz D; Nespeca M; Gidal B; Faught E; French J Epilepsy Curr; 2018; 18(4):260-268. PubMed ID: 30254527 [No Abstract] [Full Text] [Related]
5. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; Neurology; 2004 Apr; 62(8):1261-73. PubMed ID: 15111660 [TBL] [Abstract][Full Text] [Related]
6. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ; Epilepsia; 2004 May; 45(5):410-23. PubMed ID: 15101822 [TBL] [Abstract][Full Text] [Related]
8. Rufinamide in children and adults in routine clinical practice. Jaraba S; Santamarina E; Miró J; Toledo M; Molins A; Burcet J; Becerra JL; Raspall M; Pico G; Miravet E; Cano A; Fossas P; Fernández S; Falip M Acta Neurol Scand; 2017 Jan; 135(1):122-128. PubMed ID: 26923380 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of antiepileptic drugs in the adjunctive treatment of refractory partial-onset seizures: Meta-analysis of pivotal trials. Slater J; Chung S; Huynh L; Duh MS; Gorin B; McMicken C; Ziemann A; Isojarvi J Epilepsy Res; 2018 Jul; 143():120-129. PubMed ID: 29784458 [TBL] [Abstract][Full Text] [Related]
10. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Glauser T; Ben-Menachem E; Bourgeois B; Cnaan A; Chadwick D; Guerreiro C; Kalviainen R; Mattson R; Perucca E; Tomson T Epilepsia; 2006 Jul; 47(7):1094-120. PubMed ID: 16886973 [TBL] [Abstract][Full Text] [Related]
11. Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results. Laux LC; Bebin EM; Checketts D; Chez M; Flamini R; Marsh ED; Miller I; Nichol K; Park Y; Segal E; Seltzer L; Szaflarski JP; Thiele EA; Weinstock A; Epilepsy Res; 2019 Aug; 154():13-20. PubMed ID: 31022635 [TBL] [Abstract][Full Text] [Related]
12. [Antiepileptic drugs in North America]. Akiyama T; Otsubo H Brain Nerve; 2010 May; 62(5):519-26. PubMed ID: 20450099 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ; Epilepsia; 2004 May; 45(5):401-9. PubMed ID: 15101821 [TBL] [Abstract][Full Text] [Related]
14. Levetiracetam in patients with generalised epilepsy and myoclonic seizures: an open label study. Labate A; Colosimo E; Gambardella A; Leggio U; Ambrosio R; Quattrone A Seizure; 2006 Apr; 15(3):214-8. PubMed ID: 16420982 [TBL] [Abstract][Full Text] [Related]
15. Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome. Lattanzi S; Trinka E; Russo E; Striano P; Citraro R; Silvestrini M; Brigo F Drugs Today (Barc); 2019 Mar; 55(3):177-196. PubMed ID: 30938373 [TBL] [Abstract][Full Text] [Related]
16. Cannabis for the Treatment of Epilepsy: an Update. Gaston TE; Szaflarski JP Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563 [TBL] [Abstract][Full Text] [Related]
17. Retrospective study of perampanel efficacy and tolerability in myoclonic seizures. Gil-López FJ; Montoya J; Falip M; Aparicio J; López-González FJ; Toledano R; Gil-Nagel A; Molins A; García I; Serrano P; Domenech G; Torres F; Donaire A; Carreño M Acta Neurol Scand; 2018 Aug; 138(2):122-129. PubMed ID: 29573400 [TBL] [Abstract][Full Text] [Related]
18. The pharmacological management of Lennox-Gastaut syndrome and critical literature review. Verrotti A; Striano P; Iapadre G; Zagaroli L; Bonanni P; Coppola G; Elia M; Mecarelli O; Franzoni E; Liso P; Vigevano F; Curatolo P Seizure; 2018 Dec; 63():17-25. PubMed ID: 30391662 [TBL] [Abstract][Full Text] [Related]
19. Antiepileptic Drug Treatment Patterns in Women of Childbearing Age With Epilepsy. Kim H; Faught E; Thurman DJ; Fishman J; Kalilani L JAMA Neurol; 2019 Jul; 76(7):783-790. PubMed ID: 30933252 [TBL] [Abstract][Full Text] [Related]